Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
273.44 USD | -0.50% | +1.67% | +4.91% |
Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
Jan. 17 | Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks | MT |
Yield | Yield | P/E ratio | Price to Book | EV / Sales | EV / EBITDA | EV / EBIT | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
+3.30% | +3.52% | 29.94x | 22.6x | 5.92x | 10.42x | 13.26x | 147B | ||
+0.69% | +0.79% | 60.02x | 40.16x | 15.48x | 43.29x | 48.67x | 679B | ||
+1.88% | +2.40% | 26.01x | 18.35x | 9.23x | 18.62x | 20.96x | 360B | ||
+3.28% | +3.45% | 20.98x | 4.91x | 4.07x | 11.87x | 13.39x | 350B | ||
+3.68% | +3.86% | 36.51x | 39.2x | 6.38x | 14.05x | 14.52x | 299B | ||
+3.59% | +3.69% | 16.5x | 6.12x | 3.88x | 10.13x | 11.31x | 242B | ||
+3.19% | +3.35% | 13.58x | 5.14x | 4.13x | 9.87x | 11.07x | 242B | ||
+2.28% | +2.42% | 25.5x | 5.1x | 4.38x | 13.8x | 13.69x | 211B | ||
+3.80% | +3.92% | 17.78x | 4.49x | 4.2x | 10.69x | 11.16x | 198B | ||
+6.41% | +6.53% | 14.81x | 1.66x | 3.26x | 8.28x | 9.99x | 147B | ||
+3.91% | +4.17% | 16.8x | 1.63x | 2.95x | 9.88x | 10.69x | 128B | ||
+3.29% | +3.47% | 894.79x | 6.11x | 4.74x | 12.74x | 16.28x | 116B | ||
+4.18% | +4.30% | -18.42x | 6.74x | 3.23x | 27.86x | 32.49x | 116B | ||
+1.34% | +1.46% | 28.17x | 5.84x | 8.67x | 17.53x | 18.92x | 69.51B | ||
+4.44% | +4.74% | 16.02x | 3.76x | 2.23x | 6.96x | 7.72x | 68.12B | ||
+1.37% | +1.64% | 37.37x | 5.02x | 4.16x | 22.56x | 28.97x | 53.73B | ||
+1.67% | +1.92% | 22.63x | 2x | 3.69x | 14.82x | 16.47x | 41.41B | ||
+4.85% | +5.00% | 53.26x | 0.89x | 2.35x | 9.89x | 33.26x | 40.9B | ||
+0.53% | +0.58% | 46.97x | 6.26x | 9.54x | 37.48x | 39.79x | 38.86B | ||
Average | +3.04% | +3.22% | 71.54x | 9.79x | 5.39x | 16.36x | 19.61x | 186.75B | |
Weighted average by Cap. | +2.77% | +2.96% | 57.75x | 16.50x | 7.08x | 19.29x | 21.86x |
- Stock Market
- Equities
- AMGN Stock
- Sector Amgen Inc.
- Sector dividends